The Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac Diseases

Olli Arjamaa1

  • 1Biodiversity Unit, University of Turku, Turku, Finland.

CJC Open
|November 8, 2021
PubMed

Insights

Natriuretic peptides, crucial in heart disease diagnosis, may improve oxygen delivery. Their function is linked to mechanical stress and oxygen metabolism, offering new clinical research avenues.

Area of Science:

  • Cardiology
  • Physiology
  • Biochemistry

Background:

  • Circulating natriuretic peptides are vital biomarkers in cardiology, with expanding applications across medical fields.
  • Despite extensive research, the precise function of natriuretic peptides in healthy adults remains debated.
  • Current understanding links natriuretic peptide release to cardiac mechanical load, but the relationship with oxygen consumption is under-explored.

Purpose of the Study:

  • To explore the role of oxygen metabolism in the pathophysiology of natriuretic peptides.
  • To investigate the connection between mechanical stress and oxygen consumption in the context of natriuretic peptide regulation.
  • To provide a framework for understanding how natriuretic peptides might influence oxygen transport.

Main Methods:

  • Literature review and synthesis of existing published data.
  • Theoretical outlining of the interplay between mechanical stress, oxygen metabolism, and natriuretic peptide function.
  • Analysis of the potential indirect effects of natriuretic peptides on tissue oxygenation.

Main Results:

  • Mechanical load on the heart is a key regulator of natriuretic peptide synthesis and release.
  • A significant link exists between myocardial oxygen consumption and cardiac mechanical stress.
  • The natriuretic peptide system may indirectly enhance oxygen delivery through diuresis, natriuresis, and fluid shifts.

Conclusions:

  • Oxygen metabolism, influenced by mechanical stress, is a critical factor in natriuretic peptide pathophysiology.
  • The natriuretic peptide system's effects on fluid balance and hemoconcentration could optimize oxygen transport.
  • Understanding the mechanical stress-oxygen metabolism axis offers a novel perspective for clinical research and interpretation of existing studies.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
100
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
886
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
568
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
4.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K